Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment

Saved in:

Bibliographic Details
Main Authors:	Mitchell Salke, Tahrima Ferdous, Nezam Altorok
Format:	Article
Language:	English
Published:	The University of Toledo 2025-06-01
Series:	Translation
Subjects:	ANCA-associated vasculitis vasculitis avacopan
Online Access:	http://openjournals.utoledo.edu/index.php/translation/article/view/1407
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
by: Reza Zonozi, et al.
Published: (2024-06-01)

Use of Avacopan in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Estimated Glomerular Filtration Rate <15 ml/min per 1.73 m2
by: Bryce Barr, et al.
Published: (2024-04-01)

ANCA-associated Leucocytoclastic Vasculitis presenting with Bronchiectasis, GI Involvement and Hypertensive Urgency: A Complex Case without Renal Involvement
by: N. M. M. Risly, et al.
Published: (2024-12-01)

Avacopan in Anti-Neutrophil Cytoplasmic Autoantibodies–Associated Vasculitis in a Real-World Setting
by: Jonas Zimmermann, et al.
Published: (2024-09-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

Propylthiouracil-induced ANCA-associated vasculitis complicated by granulocytopenia and hemophagocytosis: a case report
by: Huilin Zhou, et al.
Published: (2025-04-01)

Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study
by: M. A. Litvinova, et al.
Published: (2025-04-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
by: O. N. Egorova, et al.
Published: (2024-10-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Pulmonary and Renal Predictors of Mortality in ANCA-Associated Vasculitis: A Regional Experience from Türkiye
by: Dilara Bulut Gökten, et al.
Published: (2025-06-01)

Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis
by: Abir Hamid, et al.
Published: (2025-05-01)

Expression of interleukin-18 in patients with renal damage induced by ANCA-associated small vasculitis and its clinical significance
by: CHEN Lin-zhou, et al.
Published: (2018-01-01)

Patients with ANCA-associated vasculitis have low serum thiol levels, and these low levels are correlated with higher disease activity scores
by: Ahmet Kor, et al.
Published: (2025-07-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

A rare adverse event of atorvastatin inducing leukocytoclastic vasculitis with ANCA‐negative (Anti‐Neutrophil cytoplasmic antibody) case report and literature review
by: Nehemias Guevara‐Rodriguez, et al.
Published: (2023-03-01)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

ANCA-related vasculitis incidence and features before and during the COVID-19 pandemic in Los Angeles, Biobio Province, Chile: an observational retrospective analysis
by: Daniel Enos, et al.
Published: (2025-06-01)

Development of a Nomogram Model to Predict Mortality in ANCA‐Associated Vasculitis Patients With Pulmonary Involvement
by: Qifang Guo, et al.
Published: (2025-04-01)

Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis
by: Ningjun Shao, et al.
Published: (2025-08-01)

A case report of metastatic renal cell carcinoma and ANCA associated vasculitis
by: Maddison Taylor, et al.
Published: (2025-07-01)

Propylthiouracil-induced vasculitis with alveolar hemorrhage after 31 years of treatment: a case report
by: Ro’a Khalaf, et al.
Published: (2024-11-01)

Clinical value of determining the markers of vascular wall damage in patients with ANCA-associated vasculitis and polyarteritis nodosa
by: L. B. Petelytska, et al.
Published: (2020-02-01)

An association between MEFV mutation and ANCA-associated vasculitis involving the central nervous system and lungs: causality under scrutiny
by: Marcus Villander Barros de Oliveira Sá, et al.
Published: (2025-02-01)

ANCA-associated vasculitis presenting with progressive binocular manifestations: a case report and literature review
by: Lei Xi, et al.
Published: (2024-12-01)

Treatment of anemia of chronic kidney disease caused by ANCA associated vasculitis with roxadustat:one case report with a literature review
by: Xiao Xiang, et al.
Published: (2021-01-01)

Pediatric antineutrophil cytoplasmic antibody-associated vasculitis: A review on pulmonary manifestations, management, and outcomes
by: Chien-Heng Lin, et al.
Published: (2024-09-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

Assessment of cardiovascular risk in patients with ANCA-associated vasculitis: A systematic review and meta-analysis
by: Aman Goyal, et al.
Published: (2024-12-01)

Value of serum amyloid A plus procalcitonin in differential diagnosis of ANCA-associated vasculitis pulmonary involvement and pulmonary bacterial infection
by: Qu Zhuan, et al.
Published: (2021-01-01)

Liver biopsy revealing anti-neutrophil cytoplasmic antibody-associated vasculitis: a tale for a challenging diagnosis
by: Bahaeddine Lahbacha, et al.
Published: (2024-12-01)

Cervical myelopathy as an atypical presentation of antineutrophil cytoplasmic antibody-associated vasculitis in a patient affected by silicosis: a case report and literature overview
by: S. Grazzini, et al.
Published: (2024-09-01)

Current Understanding of the Pathogenesis of ANCA-Associated Vasculitis and Novel Treatment Options Targeting Complement Activation
by: Konstantinos Drouzas, et al.
Published: (2025-05-01)

Integrated bioinformatic analysis of the shared molecular mechanisms between ANCA-associated vasculitis and atherosclerosis
by: Xun Hu, et al.
Published: (2024-12-01)

Investigating potential biomarkers associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis using Mendelian randomization and transcriptomic analysis
by: Yujia Wang, et al.
Published: (2025-08-01)

The Challenges of Diagnosis and Management of Wegener’s Granulomatosis with Negative ANCA
by: Lia Sasmithae
Published: (2023-07-01)

Ocular Manifestations of COVID-19 in a Patient with ANCAAssociated Vasculitis Treated with Rituximab. A Case Report
by: M. D. Suprun, et al.
Published: (2022-07-01)

Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
by: Stephen P. McAdoo, et al.
Published: (2025-06-01)

Impact of NF-κB and reactive oxygen species on intracellular BAFF/APRIL expression in ANCA-associated vasculitis: focusing on the effect of resveratrol
by: Yasuhiro Shimojima, et al.
Published: (2025-06-01)

Systemic vasculitides: сlinical cases
by: Valentina Nikolaevna Antipova, et al.
Published: (2015-09-01)